Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 3Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 11Lymphoma 11Lymphoma, Mantle-Cell 10Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 6Neoplasms 4Lymphoma, B-Cell 4Recurrence 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasm, Residual 1Melanoma 1Mature B-cell Malignancies 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Leukemia 1Heart Failure 1Extensive Stage Small Cell Lung Cancer 1Dendritic Cell Sarcoma, Interdigitating 1Cytokine Release Syndrome 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Cyclophosphamide 7acalabrutinib 4pirtobrutinib 3fludarabine 3Rituximab 3fludarabine phosphate 2Vincristine 2Melphalan 2Doxorubicin 2thymoglobulin 1obinutuzumab 1idecabtagene vicleucel 1ibrutinib 1Stem Cell Transplantation 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Mesna 1Immunotherapy, Adoptive 1Filgrastim 1Diet 1Bone Marrow Transplantation 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, B-Cell × obinutuzumab × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡